SelectQuote, Inc. operates a direct-to-consumer platform for insurance and healthcare products but remains unprofitable and niche, with a market value of about $580 million. The company leverages ...

It might be surprising for some to hear that 2024 has been a great year for stocks in the insurance industry. In fact, every single large-cap insurance stock in the United States and Canada trading ...

Earnings call SelectQuote delivered a 26% YoY revenue increase in Q1 FY2025 to $292M, driven by SelectRx growth and agent productivity in senior distribution. Adjusted EBITDA improved by $10M YoY. The ...

SelectQuote Balances Strong Execution With New Headwinds in Latest Earnings Call Management struck a cautiously optimistic tone on SelectQuote’s latest earnings call, underscoring strong operational ...

For its fiscal third quarter of 2025, SelectQuote reaped just over $408 million in total revenue, up from the more than $376 million it earned in the same period of fiscal 2024. Generally accepted ...

SelectQuote reported earnings for the 2025 fiscal-year second-quarter. The company reported earnings per share of 30 cents, beating analysts' estimate of 10 cents. Ready to turn the market’s comeback ...

SelectQuote Inc. et al., covers investors who purchased SelectQuote stock between September 9, 2020, and May 1, 2025, and alleges that the company misled the market about its business model and ...

OVERLAND PARK, Kan.--(BUSINESS WIRE)-- SelectQuote, Inc. (SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it ...

Earnings call SelectQuote reported Q2 FY25 revenue of $481M (+19% YoY) and adjusted EBITDA of $88M (+30% YoY), driven by strong Medicare Advantage policy growth and SelectRx expansion. Management ...

At the heart of the complaint are claims that SelectQuote misrepresented its Medicare Advantage sales practices. While the company publicly promoted its services as offering “unbiased advice” and ...